T
PRVA icon

TCWP’s Privia Health PRVA Stock Holding History

TCWP’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15
Closed – – 1358
2022
Q1 		$0 Buy
+15
New +$354 ﹤0.01% 1862

Other funds holding PRVA

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

TCWP's PRVA Position: Q2 2022 in Review

TCWP sold out of Privia Health (PRVA) in Q2 2022, closing a stake of 15 shares.

TCWP first reported a position in PRVA in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 151 funds tracked by Wall St. Rank hold PRVA as of Q2 2022.

  • TCWP reported no remaining Privia Health position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 15 Privia Health shares in Q2 2022.
  • TCWP first reported a position in Privia Health in Q1 2022 and held it in 1 quarter.
  • TCWP's Privia Health position peaked at $0 in Q1 2022.
  • 151 funds tracked by Wall St. Rank held Privia Health as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.